GENETIC VECTORS INC
NT 10-Q, 1997-05-15
PHARMACEUTICAL PREPARATIONS
Previous: UNIVISION COMMUNICATIONS INC, 10-Q, 1997-05-15
Next: FIRST SOUTHERN BANKSHARES INC/GA, 10QSB, 1997-05-15




                                 UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549

                                  FORM 12b-25

                          NOTIFICATION OF LATE FILING
                          ===========================

(Check One):      ___ Form 10-K  ___ Form 20-F  ___  Form 11-K
                  _X_ Form 10-Q  ___ Form N-SAR

                  For Period Ended:  03-31-97 
                  [ ] Transition Report on Form 10-K
                  [ ] Transition  Report on Form 20-F 
                  [ ]  Transition  Report on Form 11-K 
                  [ ]  Transition  Report on Form 10-Q 
                  [ ]  Transition Report on Form N-SAR
                  For the Transition Period Ended:_______________________

            Read Instruction (on back page) Before Preparing Form.
                             Please Print or Type
           Nothing in this form shall be construed to imply that the  Commission
           has verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

- ------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION

Genetic Vectors, Inc.
- ------------------------------------------------------------------------
Full Name of Registrant

Not Applicable
- ------------------------------------------------------------------------
Former Name if Applicable

2000 S. Dixie Highway, Suite 100
- ------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Miami, FL 33133
- ------------------------------------------------------------------------
City, State and Zip Code

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

         (a)      The reasons described in reasonable detail in Part III of
                  this form could not be eliminated without unreasonable
                  effort or expense;
_X_      (b)      The subject annual report, semi-annual report, transition
                  report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report of transition report on Form 10-Q, or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and 
         (c)      The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 10-Q, N-SAR,
or the transition report or portion thereof, could not be filed within the
prescribed time period.  (ATTACH EXTRA SHEETS IF NEEDED):  See Attached Sheet

PART IV - OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification

                  Mead M. McCabe, Jr.                  (305) 859-7800
         ------------------------------------------- --------------------
                  (Name)                              (Telephone Number)

(2)      Have all other periodic  reports  required under Section 13 or 15(d) of
         the  Securities  Exchange  Act of 1934 or Section 30 of the  Investment
         Company  Act of 1940  during  the  preceding  12  months  (or for  such
         shorter)  period that the registrant was required to file such reports)
         been filed? If answer is no, identify report(s).

                                                              _X_ Yes ___ No
- -------------------------------------------------------------------------
<PAGE>

(3)      Is it anticipated that any significant  change in results of operations
         from  the  corresponding  period  for  the  last  fiscal  year  will be
         reflected  by the  earnings  statements  to be  included in the subject
         report or portion thereof?

                                                              ___ Yes _X_ No

         If  so,  attach  an  explanation  of  the  anticipated   change,   both
         narratively and quantitatively,  and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

- -------------------------------------------------------------------------

                             Genetic Vectors, Inc.
           --------------------------------------------------------
                 (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: May 15, 1997             By /s/Mead M. McCabe, Jr.
                               ------------------------------
                               Mead M. McCabe, Jr., President

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                   ATTENTION
                                   =========

Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).

                             GENERAL INSTRUCTIONS

1.       This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
         Rules and Regulations under the Securities Exchange Act of 1934.

2.       One  signed  original  and  four  conformed  copies  of this  form  and
         amendments  thereto must be completed and filed with the Securities and
         Exchange  Commission,  Washington,  D.C. 20549, in accordance with Rule
         0-3 of the General Rules and Regulations under the Act. The information
         contained  in or filed  with the form  will be made a matter  of public
         record in the Commission files.

3.       A manually  signed  copy of the form and  amendments  thereto  shall be
         filed  with each  national  securities  exchange  on which any class of
         securities of the registrant is registered.

4.       Amendments to the  notifications  must also be filed on form 12b-25 but
         need not restate  information  that has been correctly  furnished.  The
         form shall be clearly identified as an amended notification.

5.       Electronic Filers.    This form shall not be used by electronic  filers
         unable to timely file  a report  solely due to electronic difficulties.
         Filers unable to submit a report within the time period  prescribed due
         to difficulties in electronic filing should comply with either Rule 201
         or Rule 202 of Regulation S-T  (Section 232.201  or  Section 232.202 of
         this chapter)  or apply for an  adjustment  in filing  date pursuant to
         Rule 13(b) of Regulation S-T (Section 232.13(b) of this chapter).
<PAGE>




                              GENETIC VECTORS, INC.
                            ATTACHMENT TO FORM 12b-25

                       REASONS FOR NOT FILING FORM 10-QSB
                       WITHIN THE PRESCRIBED TIME PERIOD
                       ---------------------------------


         To improve  the  quality  of  its  internal bookkeeping  and  financial
reporting systems  the  Registrant recently  terminated  the  employment of  its
bookkeeper.    This bookkeeper  was closely  involved  with  the preparation  of
information necessary for the finalization of the Registrant's Form 10-QSB,  and
her termination has caused unavoidable delays  in obtaining information required
for  the  Form  10-QSB.    These  delays  could  not  have  been avoided without
unreasonable effort or expense.






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission